Execs On The Move, July-August 2014
Executive Summary
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
You may also be interested in...
Game Time: FDA Releases Review Timeline Goals Set By MDUFA V
This exclusive infographic shows new review timelines the FDA announced for FY 2023 now that MDUFA V has been ratified.
Nested Therapeutics Targets Mutations Hiding In Plain Sight
Newly launched with a $90m series A funding round, the company is taking the idea behind KRAS G12C inhibitors to another level.
Not Just The Result Of Contact Sports And Combat
A pair of medical experts discuss traumatic brain injuries, their treatments, and some of the long-term complications they can cause, especially when not properly diagnosed and treated.